- Staat
- AR
- Alter
- 1,5
- Geschlecht
- M
- Eingang
- 24.03.2022
- Impfdatum
- 09.03.2022
- Beginn
- 20.03.2022
- Tage bis Beginn
- 11,0
- Dosis
- 2
- Route/Site
- SYR / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Balance disorder
Disturbance in attention
Ear infection
Febrile convulsion
Feeling abnormal
Heart rate increased
Pyrexia
Symptomtext
My son received these vaccines on 03/09/2022 and on 03/20/2022, 11 days later, he had a febrile seizure. His fever reached 104.6 on this day and it came on very quickly. He has never had a seizure before this. It is now 03/24/2022, and while he has not had another febrile seizure, I am seeing issues in his balance, and his ability to pay attention/awareness of his space. He has moments of what appears to be spacing out for up to 30 seconds.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Febrile convulsion
- Hospital-Tage
- -
- Labordaten
- He was taken by ambulance to Hospital shortly after the seizure. His fever broke after a few hours, and his heart rate lowered after being over 200 in the ambulance. He was released once both the fever and heart rate went down and he could keep fluids down. He was also diagnosed with an ear infection.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- Soy
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 5,0
- Geschlecht
- F
- Eingang
- 10.01.2022
- Impfdatum
- 06.01.2022
- Beginn
- 06.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Anaphylactic reaction
Breath sounds abnormal
Cough
Dyspnoea
Symptomtext
anaphylaxis within 10 minutes of immunizations administered - acute onset of cough without ability to catch breath, diminished lung sounds with bilateral breathing, epinephrine 0.2 mg IM administered with improvement but not resolution in lung sounds. Sent immediately to ED where patient received dose of albuterol nebulized.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Anaphylactic reaction
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- underimmunization status
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 1,5
- Geschlecht
- M
- Eingang
- 03.05.2022
- Impfdatum
- 29.04.2022
- Beginn
- 01.05.2022
- Tage bis Beginn
- 2,0
- Dosis
- 2
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Rash
Symptomtext
Rash developed all over body starting on Sunday
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 1,0
- Geschlecht
- F
- Eingang
- 18.02.2022
- Impfdatum
- 16.02.2022
- Beginn
- 16.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Cough
Irritability
Urticaria
Vomiting
Symptomtext
Infant developed hives ~ 3 hours after vaccination. Noted only on lower extremities on the day of vaccination 2/16/22. No hives on body or face, no lip or eye swelling, no coughing, runny nose, or congestion. She started vomiting when she was given solids at dinnertime on day of vaccination. Mom notes coughing preceded vomiting. Infant able to keep her formula and liquids down without vomiting. Yesterday, noted to be "weaker", not wanting to walk as much, hives worsened on the legs. No hives on the body noted. Still without fever. Infant seen in the office today (2/18/22) @ 12pm with 1 small area of urticaria on left lateral thigh, few flat patches on lower leg bilaterally. No wheezing noted, no lip/eye swelling. Infant was fussy, but consolable. No altered mental status appreciated on exam.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- subjective warmth the day prior to vaccination
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- -
- Geschlecht
- F
- Eingang
- 04.01.2023
- Impfdatum
- 02.11.2022
- Beginn
- 02.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
no adverse event; Healthcare provider reports administration of an expired dose of VAQTA to a patient on 02NOV2022; This spontaneous report was received from a health provider referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant therapies were not reported. On 02-NOV-2022, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) lot #U026792, expiration date: 28-OCT-2022, administered for prophylaxis (dose, strength, and route of administration were not provided) (expired product administered). The vaccine was not involved in a temperature excursion and was stored per the recommended storage range until date of administration. There was no adverse event (no adverse event). The follow-up information received from the health provider on 22-DEC-2022. This was a 12 months old female patient. The anatomical location for hepatitis a vaccine, inactivated (VAQTA) was thigh. There was no reaction at all. The device was not available for evaluation. Because the expired vaccine was injected into the patient's thigh. This adverse event had reported to doctor previously. The provider and patient's parents were notified. The vaccinated at private doctor's office/hospital. The vaccine/vaccine device purchased with private funds. There was no temperature excursion occur as a result of a reading from a digital data logger. The hepatitis a vaccine, inactivated (VAQTA) was pulled from stock. It was given to patient and while be entered into system was realized to be expired as soon as noticing the expiration date. It was reported to provider and parents were contacted.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- -
- Geschlecht
- U
- Eingang
- 07.12.2022
- Impfdatum
- 28.11.2022
- Beginn
- 28.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE reported.; Nurse reported a dose of VAQTA was inadvertently administered after the labeled expiration date; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. Information about the patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions/ allergies was not provided. On 28-NOV-2022 (also reported as yesterday), the patient was inadvertently vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) pre-filled syringe, dose of 0.5 mL, lot number: U026792, expiration date: 28-OCT-2022 (dose number, route of administration and anatomical location were not reported) for prophylaxis (expired product administered). The reporter confirmed that the suspect vaccine did not experience any temperature excursions. No additional adverse event (AE) was reported (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- -
- Geschlecht
- U
- Eingang
- 02.12.2022
- Impfdatum
- 23.11.2022
- Beginn
- 23.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE reported; Patient was administered expired VAQTA on 11/23/2022; This spontaneous report was received from the healthcare business professional (in charge of vaccine storage/stability) and referred to a patient of unknown age and gender. The patient's medical history, concurrent condition, drug reactions/allergies, and concomitant therapy were not reported. On 23-NOV-2022, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) intramuscular pre-filled syringe injection (valid lot #U026792 with the expiration date: 28-OCT-2022; strength, dose, and route of administration were not provided) for prophylaxis (Expired product administered). There was no temperature excursion reported. There was no additional adverse event reported (No adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- -
- Geschlecht
- U
- Eingang
- 25.11.2022
- Impfdatum
- 22.11.2022
- Beginn
- 22.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE's were reported; An office manager called to report and evaluate an expired dose of VAQTA that was administered to a patient. The office manager put a nurse on the phone to receive the evaluation results. No additional AE's and no PQC's were reported.; This spontaneous report has been received from an officer manager, regarding a patient of unknown age and gender. The patient's pertinent medical history, previous drug reactions or allergies, and concomitant medications were not reported. On 22-NOV-2022, the patient was vaccinated with an expired dose of Hepatitis A Vaccine, Inactivated (VAQTA) intramuscular injection as prophylaxis (lot number: U026792, which was determined to be valid, with an expiration date on 28-OCT-2022) (strength, dose, scheme, route and anatomical location of administration were not reported) (Expired product administered). No additional adverse event was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 09.11.2022
- Impfdatum
- 03.11.2022
- Beginn
- 03.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AEs or PQC reported; expired vaccine administered; This spontaneous report was received from a physician and referred to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies, drug reactions and allergies were not reported. On 03-NOV-2022, the patient was vaccinated with an expired vaccine of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, 0.5 milliliter (ml) intramuscular (IM), lot #U026792, expiration date: 28-OCT-2022, administered for prophylaxis (strength was not provided) (expired product administered). No additional adverse event (AE) reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 2,0
- Geschlecht
- M
- Eingang
- 03.11.2022
- Impfdatum
- 03.11.2022
- Beginn
- 03.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Vaccine expired on 10/28/2022, administered past expiration date on 11/03/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- -
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- -
- Geschlecht
- U
- Eingang
- 29.09.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
patient received VAQTA and PROQUAD that had undergone temperature excursion; No additional AE reported.; This spontaneous report was received from a healthcare worker concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history, drug reactions/allergies, and concomitant medications were not provided. On an unknown date, the patient was vaccinated with an improperly storage dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live Recombinant Human Albumin (rHA) (PROQUAD) administered as prophylaxis, lot number W006584 with reported expiration date of 12-NOV-2022, however, upon internal review it was confirmed to be 23-AUG-2023 (dosage regimen and route of administration were not provided), and a dose of Hepatitis A Vaccine, Inactivated (VAQTA) administered as prophylaxis, lot number U026792 with expiration date 28-OCT-2022 (dosage regimen and route of administration were not provided). The Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live Recombinant Human Albumin (rHA) (PROQUAD) vaccine underwent a temperature excursion of 76.1 degrees Fahrenheit (F) for 322 hours and 15 minutes, the Hepatitis A Vaccine, Inactivated (VAQTA) vaccine underwent a temperature excursion of 21.9 F for 147 hours. Both vaccines experienced previous temperature excursions (Product storage error). No additional adverse events were reported (No adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 0,2
- Geschlecht
- U
- Eingang
- 26.09.2022
- Impfdatum
- 14.09.2022
- Beginn
- 14.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Nurse reporting an AE for VAQTA that was administered to a 2 month old.; No additional AE/PQC.; This spontaneous report was received from a nurse and refers to a 2-month-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 14-SEP-2022, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, 0.5ml, lot #U026792, expiration date: 28-OCT-2022 (strength, dosing schedule and route of administration were not provided) administered for prophylaxis (product administered to patient of inappropriate age). No additional adverse event was reported (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 52,0
- Geschlecht
- M
- Eingang
- 13.09.2022
- Impfdatum
- 06.09.2022
- Beginn
- 06.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Underdose
Symptomtext
Did not have an adverse event, patient was given a pediatric dose of Hep A instead of the adult dose
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Underdose
- Hospital-Tage
- -
- Labordaten
- I spoke with our local health department on 09.06.2022 as the pharmacist was out of the office until the following week. Was told that patient would need to come back in to receive the proper adult dose.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Diabetes, HTN, Gilbert syndrome
- Andere Medikamente
- None
- Allergien
- No allergies
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- -
- Geschlecht
- U
- Eingang
- 06.07.2022
- Impfdatum
- 16.06.2022
- Beginn
- 16.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No other adverse events reported.; Caller reports that doses of improperly stored vaccines were administered to patients. Additional adverse events 02189027, 02189036, 02189037, 02189038, 02189039 and 02189040 were filed. No further information provided. No other adverse events report; This spontaneous report was received from a certified medical assistant and refers to a patient of unknown gender and age. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 16-JUN-2022, the patient was vaccinated with one dose of improperly stored hepatitis A vaccine, inactivated (VAQTA) intramuscular injection, lot #U026792, expiration date: 28-OCT-2022 (both confirmed to be valid), administered for prophylaxis (strength, route and site of administration were not provided) (product storage error). The vaccine was exposed to 47.17 degrees Fahrenheit for 15 minutes. There was no previous temperature excursion. There were no other adverse events reported. This is one of several cases from the same reporter. ; Sender's Comments: US-009507513-2206USA006061: US-009507513-2206USA006116: US-009507513-2206USA006096: US-009507513-2206USA006272: US-009507513-2206USA006141:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- -
- Geschlecht
- U
- Eingang
- 03.07.2022
- Impfdatum
- 18.06.2022
- Beginn
- 18.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No other adverse events reported; Caller reports that doses of improperly stored vaccines were administered to patients.; This spontaneous report has been received from a medical assistant concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant therapies and drug/allergy history were not reported. On 18-JUN-2022, the patient was vaccinated with the first dose of Hepatitis A Vaccine, Inactivated (VAQTA) (dose, anatomical location, route of administration were not reported) (lot# U026792, has been verified to be a valid lot number for Hepatitis A Vaccine, Inactivated (VAQTA), expiration date reported as 28-OCT-2022) as prophylaxis. The vaccine dose was improperly stored at a temperature of 47.17 Fahrenheit degrees (?F) for 15 minutes (Product storage error); with no previous temperature excursion. No other adverse events were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 8,0
- Geschlecht
- U
- Eingang
- 17.06.2022
- Impfdatum
- 02.05.2022
- Beginn
- 02.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
no adverse event; Nurse reports possible administration of improperly stored vaccines; This spontaneous report was received from Other Health Professional, referring to unspecified patients. Nurse reported possible administration of improperly stored vaccines. No additional adverse events were reported. The names of vaccines involved (including lot/exp): hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9): Lot: 1775808 Expiration: 20-AUG-2023; Lot: T030749 expiration date: 16-MAR-2023; Lot: 1687293 expiration date: 30-APR-2023; hepatitis a vaccine, inactivated (VAQTA): Lot: T031202, expiration date; 14-JUN-2022, Lot: U026792 expiration date: 28-OCT-2022; hepatitis b vaccine (recombinant) (RECOMBIVAX HB): Lot: T021327, expiration date: 14-NOV-2022; Lot: U008328, expiration date: 16-DEC-2022. All lot number were verified to be valid, (route and anatomical location were not reported) administered for prophylaxis. It was reported that the vaccines had been incorrectly stored at -0.3C for 5 minutes and then at 0.3C for 45 minutes. There was no previous temperature excursion Follow up information was received from the nurse on 09-JUN-2022. The patient's demographics were provided for all the patients involved in previous event of improperly stored vaccines. This spontaneous report was referring to a 8-year-old patient. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 02-MAY-2022, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, lot #U026792, expiration date: 28-OCT-2022, administered for prophylaxis (strength, and route of administration were not provided). This is one of multiple reports received from the same source.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NV
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 09.06.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Exposure via skin contact
No adverse event
Underdose
Syringe issue
Symptomtext
No additional AE details.; Nurse calling states she went to administer VAQTA into the thigh of a 12-month old patient and the vaccine squirted out onto his leg instead of going into his muscle. Nurse would like to know if she needs to re-vaccinate this patient. Nurse states sh; Nurse calling states she went to administer VAQTA into the thigh of a 12-month old patient and the vaccine squirted out onto his leg instead of going into his muscle. Nurse would like to know if she needs to re-vaccinate this patient. Nurse states sh; This spontaneous report has been received from a nurse, concerning to 12-months-old male patient. The patient's pertinent medical history, concurrent conditions, previous drug reactions, allergies, and concomitant medications were not provided. On an unknown date of 2022, the patient was administered vaccine hepatitis a vaccine, inactivated (VAQTA) 0.5 milliliters (ml) administered intramuscularly (valid lot number U026792 [expiration date 28-OCT-2022]) (vaccination scheme, and frequency were not provided) for prophylaxis, and the vaccine squirted out onto the patient's leg instead of going into his muscle (accidental underdose, accidental exposure to product), the reporter stated that she inspected the syringe after that happened and she did not see any cracks in the syringe and the needle was on tight. No additional adverse events (AE) details were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syringe issue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NV
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 09.06.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Exposure via skin contact
No adverse event
Underdose
Syringe issue
Symptomtext
No additional AE details.; Nurse calling states she went to administer VAQTA into the thigh of a 12-month old patient and the vaccine squirted out onto his leg instead of going into his muscle. Nurse would like to know if she needs to re-vaccinate this patient. Nurse states sh; Nurse calling states she went to administer VAQTA into the thigh of a 12-month old patient and the vaccine squirted out onto his leg instead of going into his muscle. Nurse would like to know if she needs to re-vaccinate this patient. Nurse states sh; This spontaneous report has been received from a nurse, concerning to 12-months-old male patient. The patient's pertinent medical history, concurrent conditions, previous drug reactions, allergies, and concomitant medications were not provided. On an unknown date of 2022, the patient was administered vaccine hepatitis a vaccine, inactivated (VAQTA) 0.5 milliliters (ml) administered intramuscularly (valid lot number U026792 [expiration date 28-OCT-2022]) (vaccination scheme, and frequency were not provided) for prophylaxis, and the vaccine squirted out onto the patient's leg instead of going into his muscle (accidental underdose, accidental exposure to product), the reporter stated that she inspected the syringe after that happened and she did not see any cracks in the syringe and the needle was on tight. No additional adverse events (AE) details were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syringe issue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 51,0
- Geschlecht
- M
- Eingang
- 26.05.2022
- Impfdatum
- 16.05.2022
- Beginn
- 16.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Underdose
Symptomtext
Pediatric dose was administered to an adult
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- NA
- Vorgeschichte
- anxiety, bipolar, depression
- Andere Medikamente
- Trazodone, amlodipine, sildenafil, alprazolam, hydroxyzine, paroxetine, quetiapine
- Allergien
- benadryl, lisinopril, percocet, sudafed
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 1,5
- Geschlecht
- M
- Eingang
- 11.05.2022
- Impfdatum
- 12.04.2022
- Beginn
- 12.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Wrong product administered
Symptomtext
Patient was supposed to receive Infanrix (DTaP) vaccine, was given Pediarix (DTaP-Hep B-IPV) by mistake
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 25.03.2022
- Impfdatum
- 22.03.2022
- Beginn
- 22.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect route of product administration
Symptomtext
MMR vaccine administered intramuscularly in the right thigh, instead of subcutaneously.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect route of product administration
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -